Subcutaneous versus intravenous pembrolizumab, in combination with chemotherapy, for treatment of metastatic non-small-cell lung cancer: the phase III 3475A-D77 trial

E. Felip, C.I. Rojas, M. Schenker, D.M. Kowalski, Ignacio Casarini, Tibor Csőszi, Mehmet Alı Nahıt Şendur, José Diogo Martins, Antonio Calles, C.-C. Wang, Min Wang, Rixci Augusto Lenin Ramirez Fallas, Hiroshige Yoshioka, Suresh Nair, Xiaoyu Song, Xiaoyan Deng, Mallika Lala, R. Eiras, T. Takahashi